Recombinant sheep ADRB1 is synthesized using E. coli expression systems. Key parameters include:
Radioligand Binding: Membranes expressing recombinant ADRB1 are used to study ligand affinity (e.g., sotalol, propranolol) .
GTPγS Binding: Measures G-protein activation upon receptor stimulation .
ADRB1 engages in diverse biochemical interactions :
| Function | Partner Proteins/Pathways |
|---|---|
| Ras Activation | Gs-alpha/cAMP-mediated signaling . |
| Calcium Signaling | PLC-IP3 pathways via Gq/11 proteins . |
| Beta-Arrestin Recruitment | MAPK pathway activation . |
Mechanistic Insights: Used to model heart failure and arrhythmias by studying ADRB1’s role in cardiac contractility .
Drug Screening: Evaluates β-blockers (e.g., propranolol) for therapeutic efficacy .
ADRB1 in the dorsal pons modulates wakefulness and REM sleep, as shown in murine models . Recombinant ADRB1 aids in mapping neuronal circuits involved in sleep disorders .
Commercial suppliers offer tools for ADRB1 research :
| Product Type | Examples | Applications |
|---|---|---|
| Antibodies | CSB-PA000937 (Cusabio) | WB, IHC, ELISA . |
| siRNA | MISSION® esiRNA (Sigma-Aldrich) | Gene silencing . |
| Recombinant Protein | CSB-EP630703SH1 (Cusabio) | Binding assays . |
Reconstitution: Use deionized water (0.1–1.0 mg/mL) with 50% glycerol for long-term storage .
Stability:
UniGene: Oar.519
Beta-1 adrenergic receptors mediate catecholamine-induced activation of adenylate cyclase through G proteins. These receptors bind epinephrine and norepinephrine with approximately equal affinity and play crucial roles in mediating Ras activation through G(s)-alpha and cAMP-mediated signaling pathways. ADRB1 also plays a significant role in the fight-or-flight response, coordinating with other adrenergic receptors such as beta-2 adrenergic receptor to ensure a well-rounded physiological reaction to stressors . Recent research has also identified ADRB1's involvement in the regulation of sleep/wake behaviors .
While sheep-specific ADRB1 data is limited in the provided search results, adrenergic receptors generally show strong evolutionary conservation across mammalian species. Researchers should note that despite this conservation, species-specific differences in post-translational modifications, particularly glycosylation patterns, can affect receptor function and molecular weight. For instance, mouse ADRB1 contains potential glycosylation sites that explain why it migrates at a higher molecular weight (55 kDa) than the predicted size (51 kDa) in Western blot analyses . When working with sheep ADRB1, researchers should verify sequence homology with human and mouse models while accounting for potential species-specific post-translational modifications.
ADRB1 primarily signals through the G protein-coupled pathway, activating adenylate cyclase to increase intracellular cAMP levels. This triggers downstream signaling cascades involving protein kinase A (PKA). Research has shown that ADRB1 mediates Ras activation through G(s)-alpha and cAMP-mediated signaling . Mutations in ADRB1, such as the A187V mutation identified in humans with natural short sleep patterns, can alter cAMP production in response to agonists like isoproterenol, demonstrating the critical role of this pathway in ADRB1 function . When studying recombinant sheep ADRB1, researchers should design experiments that monitor cAMP production as a primary readout of receptor functionality.
Multiple approaches can be employed to detect ADRB1 expression. Western blotting with specific antibodies has proven reliable, typically requiring 1-5 μg/mL of antibody concentration depending on the source material . Immunocytochemistry/immunofluorescence (ICC/IF) techniques are effective for visualizing cellular localization, where protocols using methanol fixation (100%, 5 minutes), followed by PBS-Tween (0.1%) permeabilization and BSA/normal serum blocking have shown good results . When designing these experiments, researchers should include proper controls and may consider dual-labeling with structural markers like alpha-tubulin to confirm subcellular localization.
Calcium imaging using fiber photometry has proven highly effective for monitoring ADRB1 neuronal activity in freely moving animals. This approach involves injecting a Cre-dependent AAV encoding fluorescent calcium indicators (such as GCaMP6s) into regions expressing ADRB1, followed by implantation of fiber optic probes for light delivery and fluorescence detection . Simultaneous EEG/EMG recordings allow correlation of neuronal activity with specific behavioral states. This method has successfully revealed that ADRB1-positive neurons in the dorsal pons are predominantly wake- and REM sleep-active . Researchers working with sheep models could adapt these techniques with appropriate stereotaxic coordinates for targeted brain regions.
Long-read sequencing technologies, such as Oxford Nanopore's MinION platform, have been successfully employed to investigate ADRB1 gene variants. The sequencing methodology involves DNA extraction, PCR amplification using specific primers (for ADRB1: forward 5′-AGACGTGCTATGTGTGACGG-3′ and reverse 5′-AGCACTTGGGGGTCGTTGTAG-3′), followed by library preparation (using kits like SQK-LSK109) and sequencing on appropriate flow cells (such as FLO-MIN106) . Bioinformatics analysis typically includes basecalling, demultiplexing, and mapping to reference sequences. This approach has demonstrated high coverage and accuracy for ADRB1 regions with aligned read numbers reaching well over 100,000 per sample in published studies .
Mutations in ADRB1 can significantly alter receptor function with profound physiological consequences. Research on the A187V mutation found in human subjects with natural short sleep patterns demonstrated decreased cAMP production in response to isoproterenol treatment compared to wild-type receptors . When this mutation was engineered into mice, it resulted in approximately 55 minutes less sleep within a 24-hour period, specifically in the dark phase, affecting both NREM and REM sleep primarily through reduction in sleep bout numbers rather than episode duration . These mutant mice accumulated more sleep pressure, as evidenced by higher delta power at the beginning of the light phase (ZT1-2) . When investigating sheep ADRB1 variants, researchers should consider functional assays measuring cAMP production along with downstream physiological outcomes specific to the system under study.
ADRB1 is expressed at high levels in specific brain regions, particularly the dorsal pons (DP). Characterization of these neurons has revealed that ADRB1-positive cells in the DP are predominantly glutamatergic (~37%) or GABAergic (~25%), with very few cholinergic or noradrenergic cells . This neurochemical profile provides insight into how these neurons integrate into broader neural circuits. Calcium imaging studies have demonstrated that these ADRB1-positive neurons are primarily active during wakefulness and REM sleep, and experimental manipulation of their activity directly affects sleep/wake patterns . This suggests a critical role for ADRB1-expressing neurons in sleep regulation. Researchers working with sheep models should consider similar neuroanatomical mapping approaches to establish species-specific distribution patterns.
ADRB1 functions in concert with other adrenergic receptors, particularly beta-2 adrenergic receptor (ADRB2), to coordinate physiological responses to stress and other stimuli . This coordination is essential for a well-rounded fight-or-flight response. Studies investigating both ADRB1 and ADRB2 have employed similar methodological approaches, though detection sensitivity may vary significantly between the two receptor subtypes as demonstrated by sequencing studies showing much higher aligned read numbers for ADRB1 compared to ADRB2 . Understanding these receptor interactions requires comprehensive experimental designs that can simultaneously monitor multiple receptor subtypes and their downstream effectors.
Variability in ADRB1 expression presents significant challenges for data interpretation. Researchers should implement robust normalization strategies, including the use of multiple housekeeping genes as references and consider tissue-specific controls. When analyzing fiber photometry data from ADRB1-expressing neurons, for example, researchers have addressed variability by comparing relative signal amplitude between active and sleep phases within the same animal rather than directly comparing absolute values between different animals . This approach controls for variations in virus expression levels around optical fiber tips. For protein-level analyses using Western blotting, consistent loading controls and careful quantification methods are essential for reliable comparisons.
Analysis of ADRB1 sequencing data requires rigorous statistical methods to identify significant variants. For long-read sequencing approaches, quality filtering based on sequence scores is an essential first step before mapping to reference sequences . Coverage metrics are critical for assessing reliability, with studies showing successful analyses achieving >100,000 aligned reads for ADRB1 regions . As demonstrated in the table below from published research, coverage can vary significantly across samples:
| Barcode | Received data size (MB fastq/barcode) | ADRB1 Aligned Read number |
|---|---|---|
| NBD01 | 137 | 137701 |
| NBD02 | 183 | 165975 |
| NBD03 | 95 | 87236 |
| NBD04 | 168 | 156156 |
| NBD05 | 88 | 96652 |
Bioinformatics tools like Geneious Prime and validation through platforms such as VarSome Tools enhance the reliability of variant detection . For comparing variant frequencies between experimental groups, chi-square or Fisher's exact tests are typically employed, with appropriate corrections for multiple testing.
Distinguishing direct cellular effects from circuit-level consequences presents a significant challenge in ADRB1 research. When examining changes in neuronal activity following genetic manipulation of ADRB1 (such as the A187V mutation), researchers have observed that mutant mice exhibited a 34% increase in fluorescence signal while spending only 9% more time in wakefulness, suggesting that the change could not be solely attributed to altered behavior . To address this challenge, researchers have employed acute isolated tissue preparations for single-cell imaging, effectively removing circuit-level influences. Complementary approaches include pharmacological interventions with specific agonists or antagonists, designer receptors exclusively activated by designer drugs (DREADDs), and temporally precise optogenetic manipulations that can help dissect direct receptor effects from downstream network consequences.
Recent discoveries linking ADRB1 mutations to natural short sleep patterns have opened new avenues for sleep medicine research. The identification of the A187V mutation in human subjects with familial natural short sleep and subsequent validation in mouse models has established ADRB1 as a critical regulator of sleep/wake behaviors . Current research focuses on understanding how ADRB1-expressing neurons in the dorsal pons regulate sleep architecture through their primarily wake-active and REM sleep-active patterns . Future directions may include developing targeted therapeutics that modulate ADRB1 signaling to address sleep disorders without the side effects associated with current medications. Researchers working with sheep models might consider investigating breed-specific sleep patterns in relation to ADRB1 variants as a translational approach.
ADRB1 research has provided insights into cardiac conditions such as Takotsubo Syndrome, a stress-induced cardiomyopathy. Studies comparing ADRB1 gene expression between Takotsubo patients and healthy controls have employed comprehensive genomic analyses focusing on structural variations . While no structural variations in ADRB1 leading to Takotsubo Cardiomyopathy were detected in one study, the methodology established—involving DNA extraction, specific primer designs, and long-read sequencing—provides a robust framework for future investigations . Ongoing research continues to explore how adrenergic signaling contributes to stress-induced cardiac dysfunction, with potential implications for targeted therapeutic approaches.
Technological innovations have significantly enhanced ADRB1 research capabilities. Fiber photometry combined with genetically encoded calcium indicators now allows for real-time monitoring of ADRB1-expressing neuronal activity in freely moving animals, correlating cellular activity with behavioral states . CRISPR/Cas9 gene editing has enabled precise introduction of specific mutations, such as the A187V variant, facilitating direct assessment of functional consequences in animal models . Advanced sequencing technologies, including long-read approaches using platforms like Oxford Nanopore's MinION, provide comprehensive coverage of ADRB1 genetic variations with high accuracy . Future directions may include single-cell transcriptomics to characterize ADRB1-expressing cell populations with unprecedented resolution and the development of more selective pharmacological tools to probe receptor function in specific tissues or cell types.